"For almost 30 years, the coordinated team of specialists at Riverhills Neuroscience have provided expert diagnosis and treatment for complex conditions of the nervous system. Each physician brings his or her unique personality, compassion, and depth of learning to the treatment of challenging conditions- providing highly personalized care in a comfortable, healing environment."

During the past decade, Riverhills Healthcare, Inc conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverhills Healthcare, Inc" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 2 trials, followed by "Ipsen" with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Cognition Pharmaceuticals, LLC" with 1 trials sponsored and "DePuy Spine" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverhills Healthcare, Inc" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Riverhills Healthcare, Inc" are "Multiple Sclerosis" (5 trials), "Adult Lower Limb Spasticity" (1 trials), "Cervical Dystonia" (1 trials), "Cognition Disorders" (1 trials) and "Constipation" (1 trials). Many other conditions were trialed in "Riverhills Healthcare, Inc" in a lesser frequency.

Most popular intervention types in "Riverhills Healthcare, Inc" are "Drug" (9 trials), "Device" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cladribine Tablets" (2 trials), "C105" (1 trials), "DaxibotulinumtoxinA" (1 trials) and "Droxidopa capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Riverhills Healthcare, Inc" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Riverhills Healthcare, Inc". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Riverhills Healthcare, Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Riverhills Healthcare, Inc, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".